The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Personalised 3D Printed Medicines: Which Techniques and Polymers Are More Successful?
Open accessAbstract
The interindividual variability is an increasingly global problem when treating patients from different backgrounds with diverse customs, metabolism, and necessities. Dose adjustment is frequently based on empirical methods, and therefore, the chance of undesirable side effects to occur is high. Three-dimensional (3D) Printed medicines are revolutionsing the pharmaceutical market as potential tools to achieve personalised treatments adapted to the specific requirements of each patient, taking into account their age, weight, comorbidities, pharmacogenetic, and pharmacokinetic characteristics. Additive manufacturing or 3D printing consists of a wide range of techniques classified in many categories but only three of them are mostly used in the 3D printing of medicines: printing-based inkjet systems, nozzle-based deposition systems, and laser-based writing systems. There are several drawbacks when using each technique and also the type of polymers readily available do not always possess the optimal properties for every drug. The aim of this review is to give an overview about the current techniques employed in 3D printing medicines, highlighting their advantages, disadvantages, along with the polymer and drug requirements for a successful printing. The major application of these techniques will be also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The return of a forgotten polymer—Polycaprolactone in the 21st century
Woodruff, M. A., & Hutmacher, D. W. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.04.002 · Cited by 4,033 · cited 6×
“The polymer is, however, bioresorbable, even though the process is longer, starting with a hydrolitic degradation (Figure 7) [34].”
BackgroundInfluentialFarah, S., Anderson, D. G., & Langer, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.012 · Cited by 3,443 · cited 7×
“PLA homopolymer has a melting point of 150–175 °C and a Tg of 55 °C [6,31].”
BackgroundMethodInfluentialBiomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206 · cited 6×
“Polyacid-L-lactic (PLLA) X X Biodegradable aliphatic polyester that comes from renewable resources such as corn starch, tapioca roots or sugar cane FDM [12,15,17,18]”
BackgroundMethodInfluentialRecent advances in 3D printing of biomaterials
Chia, H. N., & Wu, B. M. (2015) · Journal of Biological Engineering · doi:10.1186/s13036-015-0001-4 · Cited by 1,734
Synthesis of polycaprolactone: A review
Labet, M., & Thielemans, W. (2009) · Chemical Society Reviews · doi:10.1039/b820162p · Cited by 1,673
A review of polyvinyl alcohol and its uses in cartilage and orthopedic applications
Baker, M. I., Walsh, S. P., Schwartz, Z., & Boyan, B. D. (2012) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.32694 · Cited by 1,111
Medical Applications for 3D Printing: Current and Projected Uses.
Ventola, C. L. (2014) · PubMed Central · Cited by 920
3D printing in pharmaceutics: A new tool for designing customized drug delivery systems
Goole, J., & Amighi, K. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.071 · Cited by 660
Stereolithographic (SLA) 3D printing of oral modified-release dosage forms
Wang, J., Goyanes, A., Gaisford, S., & Basit, A. W. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.016 · Cited by 612
Khaled, S. A., Burley, J. C., Alexander, M. R., Yang, J., & Roberts, C. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.028 · Cited by 606
Cited by
The Role of 3D Printing in Medical Applications: A State of the Art
Aimar, A., Palermo, A., & Innocenti, B. (2019) · Journal of Healthcare Engineering · doi:10.1155/2019/5340616 · Cited by 685
3D bioprinting of tissues and organs for regenerative medicine
Vijayavenkataraman, S., Yan, W.-C., Lu, W. F., Wang, C.-H., & Fuh, J. Y. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.004 · Cited by 630
Serrano, D. R., Luciano, F. C., Anaya, B. J., Ongoren, B., Kara, A., Molina, G., Ramirez, B. I., Sánchez-Guirales, S. A., Simon, J. A., Tomietto, G., et al. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101328 · Cited by 488
Self-citation3D printing technology; methods, biomedical applications, future opportunities and trends
Bozkurt, Y., & Karayel, E. (2021) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2021.07.050 · Cited by 384
Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020124 · Cited by 356
Shen, X., Zheng, Q., & Kim, J.-K. (2021) · Progress in Materials Science · doi:10.1016/j.pmatsci.2020.100708 · Cited by 264
Polymeric Systems for Bioprinting
Bedell, M. L., Navara, A. M., Du, Y., Zhang, S., & Mikos, A. G. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00834 · Cited by 258
Stereolithography 3D printing technology in pharmaceuticals: a review
Deshmane, S., Kendre, P., Mahajan, H., & Jain, S. (2021) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2021.1994990 · Cited by 103
Metadata
- Authors
- Konta, A., García-Piña, M., & Serrano, D.
- Venue
- Bioengineering
- Publisher
- MDPI AG
- Published
- 2017-09-22
- Volume
- 4
- Issue
- 4
- Pages
- 79
- ISSN
- 2306-5354 (ISSN-L)
- OpenAlex
- W2760581635
- Cited by
- 301
- References
- 34
- FWCI
- 14.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.